Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Debt/Equity

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Total Debt/Equity(x) 0.190.180.180.170.33

What is the latest Total Debt/Equity ratio of NATH BIOGENES (INDIA) ?

The latest Total Debt/Equity ratio of NATH BIOGENES (INDIA) is 0.19 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.19
Mar20240.18
Mar20230.18
Mar20220.17
Mar20130.33

How is Total Debt/Equity of NATH BIOGENES (INDIA) Trending?

Years Total Debt/Equity % Change
Mar2025 0.19
5.56
Mar2024 0.18
0.00
Mar2023 0.18
5.88
Mar2022 0.17
-48.48
Mar2013 0.33 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Total Debt/Equity ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹325.9 Cr 3.9% 0.4% -21.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,352.2 Cr 8.5% 1.9% -36.3% Stock Analytics
KAVERI SEED COMPANY ₹5,449.7 Cr 0.1% -10.7% 5.9% Stock Analytics
VENKYS (INDIA) ₹2,143.3 Cr 2.4% 2.1% -24.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,325.4 Cr -1.8% -10.9% -31.5% Stock Analytics
INDO US BIOTECH ₹267.4 Cr 1.6% -8.1% -54.3% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.9%

0.4%

-21.6%

SENSEX

1.7%

1.5%

-3%


You may also like the below Video Courses